European Environmentally Related Tax Revenue from Taxes on Pollution in Manufacturing of Basic Pharmaceutical Products and Pharmaceutical Preparations Share by Country (Million US Dollars PPP = 2015)

The European environmentally related tax revenue from pollution in the pharmaceutical manufacturing sector presents a varied landscape. In 2023, France led with an increase of over 4%, while Ireland experienced a significant boost of more than 33%. Countries like Hungary, Serbia, and Portugal also showed positive growth. In contrast, the United Kingdom, Netherlands, and Italy faced notable declines. Over a longer period, Germany and Ireland displayed a consistent uptrend, while other countries depicted fluctuations due to policy changes and industry shifts.

Looking ahead, future trends to watch include the impact of evolving environmental regulations and growing emphasis on sustainable practices within the pharmaceutical industry. The shift towards greener manufacturing processes may affect tax structures and revenue, potentially leading to increased revenues in countries that quickly adapt to these changes. The development of new policies, such as carbon pricing, could also play a significant role in influencing tax revenues across Europe. Monitoring these factors will be crucial for understanding the trajectory of environmentally related tax revenues in this sector.